Corporate information

Official name
Mylan Inc
Registration country

Company type

Global pharmaceutical company.

Overview

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world.



Funding rounds

Profile Country
TPG Capital LP Private equity firm

Profile Country
TPG Growth LLC The middle market and growth equity investment platform of TPG.

Profile Country Notes
Viatris Initial investment. Led the round.

Top investment portfolio themes

Actual initial investment stage
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
Zyomyx Inc Developer of protein chips. Venture Initial investment led the round

Current team

Past employees

Selected Products / Customers

Financials